Your browser doesn't support javascript.
loading
Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice.
Harmon, Gregory S; Dumlao, Darren S; Ng, Damian T; Barrett, Kim E; Dennis, Edward A; Dong, Hui; Glass, Christopher K.
Affiliation
  • Harmon GS; Department of Medicine, University of California-San Diego, La Jolla, California, USA. gharmon@ucsd.edu
Nat Med ; 16(3): 313-8, 2010 Mar.
Article in En | MEDLINE | ID: mdl-20154695
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Carbonic Anhydrase IV / Thiazolidinediones / PPAR gamma / Hypoglycemic Agents Type of study: Etiology_studies Limits: Animals Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2010 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Carbonic Anhydrase IV / Thiazolidinediones / PPAR gamma / Hypoglycemic Agents Type of study: Etiology_studies Limits: Animals Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2010 Document type: Article Affiliation country: Estados Unidos